These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 4914553

  • 1. [An attempt to prevent lymphoid atrophy in secondary disease of radiation chimeras by means of transplanting the lymphocytes of a recipient].
    Koval'chuk LV, Zaretskaia IuM.
    Biull Eksp Biol Med; 1967 Oct; 63(10):82. PubMed ID: 4914553
    [No Abstract] [Full Text] [Related]

  • 2. Prevention of graft-versus-host disease by Fab fragments derived from ALG.
    Richie ER, Gallagher MT, Trentin JJ.
    Transplant Proc; 1973 Mar; 5(1):873-6. PubMed ID: 4144467
    [No Abstract] [Full Text] [Related]

  • 3. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
    Johnson BD, Drobyski WR, Truitt RL.
    Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
    [Abstract] [Full Text] [Related]

  • 4. From radiation chimeras to 1988.
    van Bekkum DW.
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():216-21. PubMed ID: 2565747
    [No Abstract] [Full Text] [Related]

  • 5. Interferon-gamma-mediated prevention of graft-versus-host disease: development of immune competent and allo-tolerant T cells in chimeric mice.
    Brok HP, Vossen JM, Heidt PJ.
    Bone Marrow Transplant; 1997 Mar; 19(6):601-6. PubMed ID: 9085739
    [Abstract] [Full Text] [Related]

  • 6. Studies on immunologic unresponsiveness during secondary disease. II. The effect of added donor and host immunologically competent cells.
    Thompson JS, Simmons EL, Moy RH, Crawford MK.
    J Immunol; 1967 Jan; 98(1):179-85. PubMed ID: 5335178
    [No Abstract] [Full Text] [Related]

  • 7. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
    Hirano M, Arase H, Arase-Fukushi N, Ogasawara K, Iwabuchi K, Miyazaki T, Good RA, Onoé K.
    Cell Immunol; 1993 Oct 01; 151(1):118-32. PubMed ID: 8402923
    [Abstract] [Full Text] [Related]

  • 8. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR, Majewski D, Hanson G.
    Biol Blood Marrow Transplant; 1999 Oct 01; 5(4):222-30. PubMed ID: 10465102
    [Abstract] [Full Text] [Related]

  • 9. Antidonor immunologic reactions of long-standing radiation chimeras.
    van Bekkum DW, Roodenburg J.
    Transplant Proc; 1973 Mar 01; 5(1):881-6. PubMed ID: 4572150
    [No Abstract] [Full Text] [Related]

  • 10. Low-dose heparin inhibits acute graft versus host disease in mice.
    Naparstek E, Slavin S, Weiss L, Sidi H, Ohana M, Reich S, Vlodavsky I, Cohen IR, Naparstek Y.
    Bone Marrow Transplant; 1993 Sep 01; 12(3):185-9. PubMed ID: 8241974
    [Abstract] [Full Text] [Related]

  • 11. Murine models of graft-versus-host disease with features of scleroderma.
    Charley MR, Deng JS.
    Immunol Ser; 1989 Sep 01; 46():625-40. PubMed ID: 2488872
    [No Abstract] [Full Text] [Related]

  • 12. Preventive effect of ultraviolet radiation on murine chronic sclerodermatous graft-versus-host disease.
    Mermet I, Kleinclauss F, Marandin A, Guérrini JS, Angonin R, Tiberghien P, Saas P, Aubin F.
    Transplantation; 2007 Dec 27; 84(12):1696-700. PubMed ID: 18165783
    [Abstract] [Full Text] [Related]

  • 13. Risk of donor lymphocyte infusions following allogeneic bone marrow transplantation.
    van Bekkum DW, Kinwel-Bohré EP.
    Exp Hematol; 1997 Jun 27; 25(6):478-80. PubMed ID: 9197324
    [Abstract] [Full Text] [Related]

  • 14. Donor lymphoid cells of Th2 cytokine phenotype reduce lethal graft versus host disease and facilitate fully allogeneic cell transfers in sublethally irradiated mice.
    Fowler DH, Kurasawa K, Smith R, Gress RE.
    Prog Clin Biol Res; 1994 Jun 27; 389():533-40. PubMed ID: 7700918
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Secondary disease of radiation chimera].
    Zaĭtseva KK.
    Arkh Patol; 1967 Jun 27; 29(6):3-11. PubMed ID: 4882591
    [No Abstract] [Full Text] [Related]

  • 20. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
    Weiss L, Lubin I, Factorowich I, Lapidot Z, Reich S, Reisner Y, Slavin S.
    J Immunol; 1994 Sep 15; 153(6):2562-7. PubMed ID: 8077666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.